BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim H, Park E, Kim J, Boon-yasidhi V, Tarugsa J, Reyes A, Manalo S, Joung Y. Aripiprazole for Irritability in Asian Children and Adolescents with Autistic Disorder: A 12-Week, Multinational, Multicenter, Prospective Open-Label Study. Journal of Child and Adolescent Psychopharmacology 2018;28:402-8. [DOI: 10.1089/cap.2017.0152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Iasevoli F, Barone A, Buonaguro EF, Vellucci L, de Bartolomeis A. Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review. Expert Opinion on Drug Safety 2020;19:1419-44. [DOI: 10.1080/14740338.2020.1820985] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Vanderwall R, Rotta K, Ehrhardt K, Poling A. Using Aripiprazole to Benefit People with Autism Spectrum Disorder: a Critical Appraisal. Adv Neurodev Disord 2021;5:1-10. [DOI: 10.1007/s41252-020-00190-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 DeMayo MM, Young LJ, Hickie IB, Song YJC, Guastella AJ. Circuits for social learning: A unified model and application to Autism Spectrum Disorder. Neurosci Biobehav Rev 2019;107:388-98. [PMID: 31560922 DOI: 10.1016/j.neubiorev.2019.09.034] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
4 Coustals N, Ménard ML, Cohen D. Aripiprazole in Children and Adolescents. J Child Adolesc Psychopharmacol 2021;31:4-32. [PMID: 32931315 DOI: 10.1089/cap.2020.0014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]